RRO News update

RRO News

NAGANO Training workshops:

  • Thursday, December 15 from 1 p.m. to 3 p.m.

To register, please contact Jordan:  cer@jgh.mcgill.ca.


Webinar November 17, from 11:00 am to 12:30 pm

The Canadian Associate of Research Ethics Boards (CAREB) is presenting a Foundational Skills webinar " How to Review a Protocol in the Social Sciences and Humanities Series – Concern for Participant Welfare, Justice and Autonomy " (Part 4 of 4).

The speaker is Linda Furlini, Research Ethics Advisor, Academic Affairs and Research Ethics, CIUSSS West-Central Montreal.

The webinar costs $30.00.  

⇒ Please register
 at the CAREB-ACCER Webinar Store to receive the  link.


NEW! – The Board of our CIUSSS has just approved the Standard Operating Procedures (SOPs) of the CIUSSS West-Central Montreal Research Ethics Board (September 2021). These SOPs were developed based on the Canadian REB SOPs by the Canadian Association of Research Ethics Boards (CAREB) in 2014, which were then further adapted by CATALIS for the Quebec context in 2019.

These SOPs are aimed to all clinical researchers of the Jewish General Hospital and researchers within the community sector having research privileges at the CIUSSS West-Central Montreal.

Access to the document:  SOPs 2021.


Clinical Trials in Quebec

*2021 : Two new features to harmonize the evaluation of clinical trials across Quebec :

  • Updated "Standard Legal Clauses of Information and Consent Forms in Clinical Trials" ( MSSS,2021).
     
  • Updated multicenter evaluation process in Nagano (March 15, 2021). Consult the video clips intended for researchers and research teams:

 http://formations.nagano.ca/

*2022: Food and Drug Administration Regulatory Standard:  form FDA 1572 clinical trials: exemption in Quebec

CATALIS and its network of private and public partners have prepared a memo which serves to clarify the requirements for the signing of form FDA 1572 in both Quebec and the rest of Canada as applicable to clinical trials.

Although signing FDA 1572 is a regulatory obligation and thus a contractual requirement in agreements for sites in the United States that are participating in clinical trials regulated by the Food and Drug Administration (FDA), sites located within Quebec’s health and social services network must be exempt from this requirement and from the requirements relating to research ethics boards’ composition and operating methods.

See further information on CATALIS web site: in  English.


 

Page last updated on 

We always seek feedback to make our site better.